More Substance Use News and Updates

In 2022, 1 in 5 overdose deaths in the United States involved people with mental health disorders (MHD) unrelated to substance use, according to a study published in Morbidity and Mortality Weekly Report.

Kenneth J. Martz, PsyD, MBA, discusses how neuroplasticity can amplify traditional recovery techniques.

Three-quarters of US residents in a national survey did not know primary care physicians (PCPs) could prescribe medications for people with opioid use disorder (OUD) or believed incorrectly that they could not, according to a study findings...

Buprenorphine, whether administered sublingually or subcutaneously, appears to be an effective option for the treatment of opioid use disorder (OUD) with fentanyl use.

A pharmacokinetics study of AD04, a potential treatment for AUD, is designed to meet an FDA requirement for an upcoming phase 3 trial and is expected to last 6 months.

Insomnia symptoms, even if mild, were found to be associated with increased drinking over time, according to findings from the “first study to examine if objective circadian measures can predict future alcohol use in adults.”

Harm reduction services for people with SUD demonstrate efficacy, but they continue to encounter social stigma and barriers, according to a poster presentation at the RX and Illicit Drug Summit.